Article Excerpt: WB001 is an investigational digital therapeutic, delivered over eight weeks via a patient’s smartphone, that combines cognitive behavioural therapy (CBT) and elements of interpersonal psychotherapy (IPT) with a deep understanding of the lived experience of PPD to reduce symptoms of depression. Intended as a prescription-only treatment to be used under the supervision of a clinician, WB001 also features the company’s relational agent Woebot, which was shown in a recent study to be capable of forming a bond with patients to support meaningful engagement and, potentially, better outcomes.
Full Article: https://tinyurl.com/tpzpmt6a
Article Source: Med-Tech